Last edition
News about "digital drug discovery platforms"
Converge Bio Uses ConvergeAB to Enhance Cancer Treatment
Converge Bio uses its ConvergeAB AI platform to enhance cetuximab, achieving 2x higher receptor binding affinity and improved cancer signal blocking, with findings supporting a provisional patent filing.
Digital Drug Discovery Platforms | 06/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members